miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21-Reference-Cited by-同舟云学术

miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21

Published:2017-06 Issue: Volume:90 Page:517-523
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zheng Ruzhen,Liu Yuehua,Zhang Xiaoling,Zhao Pengjun,Deng Qinghua

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference48 articles.

1. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis;Njei;J. Gastroenterol. Hepatol.,2016

2. Chemotherapy to patients with metastatic carcinoma of the esophagus and gastro-esophageal junction. A survey of a Cochrane review;Vestermark;Ugeskr. Laeger,2008

3. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N. Engl. J. Med.,2012

4. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals;Merkow;Ann. Surg. Oncol.,2012

5. DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population;Yu;Thoracic Cancer,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-335-5p Inhibits EMT and PI3K/AKT Pathways via MARCH8;Indian Journal of Clinical Biochemistry;2024-01-08

2. Restoration of miR-200c sensitizes breast cancer cells to cytarabine;2023-12-20

3. hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox;Genetic Testing and Molecular Biomarkers;2023-12-01

4. Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches;Cell Biology and Toxicology;2023-06-20

5. The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer;Pathology - Research and Practice;2023-06